RT Journal Article
SR Electronic
T1 Synthetic Population Generation with Public Health Characteristics for Spatial Agent-Based Models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.18.24312662
DO 10.1101/2024.09.18.24312662
A1 Von Hoene, Emma
A1 Roess, Amira
A1 Kavak, Hamdi
A1 Anderson, Taylor
YR 2024
UL http://medrxiv.org/content/early/2024/09/19/2024.09.18.24312662.abstract
AB Agent-based models (ABMs) simulate the behaviors, interactions, and disease transmission between individual “agents” within their environment, enabling the investigation of the underlying processes driving disease dynamics and how these processes may be influenced by policy interventions. Despite the critical role that characteristics such as health attitudes and vaccination status play in disease outcomes, the initialization of agent populations with these variables is often oversimplified, overlooking statistical relationships between attitudes and other characteristics or lacking spatial heterogeneity. Leveraging population synthesis methods to create populations with realistic health attitudes and protective behaviors for spatial ABMs has yet to be fully explored. Therefore, this study introduces a novel application for generating synthetic populations with protective behaviors and associated attitudes using public health surveys instead of traditional individual-level survey datasets from the census. We test our approach using two different public health surveys (one national and the other representative of the study area, Virginia, U.S.) to create two synthetic populations representing individuals aged 18 and over in Virginia, U.S., and their COVID-19 vaccine attitudes and uptake as of December 2021. Results show that integrating public health surveys into synthetic population generation processes preserves the statistical relationships between vaccine uptake and attitudes in different demographic groups while capturing spatial heterogeneity at fine scales. This approach can support disease simulations that aim to explore how real populations might respond to interventions and how these responses may lead to demographic or geographic health disparities. Our study also demonstrates the potential for initializing agents with variables relevant to public health domains that extend beyond infectious diseases, ultimately advancing data-driven ABMs for geographically targeted decision-making.Author Summary In this study, we introduce a new method for generating synthetic populations of individuals or “agents” with characteristics that include health protective behaviors and attitudes, which are crucial for modeling disease spread. Traditional methods for parameterizing agents often overlook the complex relationships between demographic factors and health behaviors like vaccination. Additionally, detailed spatial data capturing these behaviors are limited, meaning agent behaviors are more uniform across geographic space. By fitting public health surveys with spatially aggregated census data, we created more realistic agent populations for disease spread simulations. We focused on Virginia, U.S. and generated a population with COVID-19 vaccine uptake and attitudes as of December 2021. Our results show that this approach captures the statistical relationships between demographic variables and vaccine uptake, along with the spatial variation in these behaviors. We also show that using national survey data is comparable to using local survey data representative of Virginia collected in 2021. The approach is flexible so that it can be applied to various public health studies beyond just infectious diseases. Our work highlights the potential of public health surveys for enhancing synthetic population generation, offering a valuable approach for initializing models with more realistic populations to explore public health challenges.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by National Science Foundation (Award #230970 and #2109647).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:(IRB 1684418-3) IRB of George Mason University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes